ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)

Clinical Trial Site, La Jolla, California, United States

Clinical Trial Site, Los Angeles, California, United States

Clinical Trial Site, Jacksonville, Florida, United States

Clinical Trial Site, Iowa City, Iowa, United States

Clinical Trial Site, Kansas City, Kansas, United States

Clinical Trial Site, Baltimore, Maryland, United States

Clinical Trial Site, Boston, Massachusetts, United States

Clinical Trial Site, New York, New York, United States

Clinical Trial Site, Durham, North Carolina, United States

Clinical Trial Site, Columbus, Ohio, United States

Clinical Trial Site, Philadelphia, Pennsylvania, United States

Clinical Trial Site, Austin, Texas, United States

Clinical Trial Site, Houston, Texas, United States

Clinical Trial Site, Salvador, Brazil

Clinical Trial Site, São Paulo, Brazil

Clinical Trial Site, Sofia, Bulgaria

Clinical Trial Site, Aarhus, Denmark

Clinical Trial Site, Copenhagen, Denmark

Clinical Trial Site, Bordeaux, France

Clinical Trial Site, Bron, France

Clinical Trial Site, Créteil, France

Clinical Trial Site, Le Kremlin-Bicêtre, France

Clinical Trial Site, Marseille, France

Clinical Trial Site, Berlin, Germany

Clinical Trial Site, Giessen, Germany

Clinical Trial Site, Hanover, Germany

Clinical Trial Site, Jerusalem, Israel

Clinical Trial Site, Ramat Gan, Israel

Clinical Trial Site, Milan, Italy

Clinical Trial Site, Naples, Italy

Clinical Trial Site, Palermo, Italy

Clinical Trial Site, Roma, Italy

Clinical Trial Site, Groningen, Netherlands

Clinical Trial Site, Lisbon, Portugal

Clinical Trial Site, Porto, Portugal

Clinical Trial Site, Barcelona, Spain

Clinical Trial Site, Madrid, Spain

Clinical Trial Site, Palma, Spain

Clinical Trial Site, New Taipei City, Taiwan

Clinical Trial Site, Taipei, Taiwan